***Background.*** The objective of this study was to investigate clinical characteristics, risk factors of community-acquired acute pyelonephritis (CA-APN) caused by fluoroquinolone-resistant (FQ-R) uropathogen, and clinical response according to FQ MICs of uropathogen.

***Methods.*** We performed prospective observational study, which collected clinical data of CA-APN women with identified urinary pathogen from urine or blood cultures visiting 11 university hospital from March 2010 to February 2012.

***Results.*** Among 775 CA-APN patients, 587 with FQ susceptibility results were analyzed. Numbers of FQ-R and fluoroquinolone-susceptible (FQ-S) group were 127 (21.6%) and 460 (78.4%). In clinical characteristics, more patients in FQ-R group had an age \>65 years (56.7% vs 44.6%, *p* = 0.015), history of antibiotics usage within 1 year (48.1% vs 24.3%, *p* \< 0.001), history of admission within 1 year (43.7% vs 22.8%, *p*\<0.001), Charlson co-morbidity index \>1 (26.8% vs 21.3%, *p* = 0.191), and extended-spectrum β-lactamase positivity (27.2% vs 4.2%, *p* \< 0.001). Clinical response within 72 hours (early clinical response, ECR), final clinical response and mortality were not different between the two groups, although duration of hospitalization was longer in FQ-R group (median 9.0 vs 7.0 days, *p =* \>0.001). In subgroup of 142 subjects using FQ during initial 72 hours, final clinical response or mortality was not different between the two groups. However, ECR was more frequent (50.0% vs 75.0%, *p* = 0.012) and duration of hospitalization was shorter (median 10.5 vs 7.0 days, *p*\<0.001) in FQ-S than FQ-R group. Multivariate logistic regression proved that age \>65 years (OR 1.572, CI 1.004-2.460, *p* = 0.048) and history of antibiotics usage within 1year (OR 2.902, CI 1.842-4.573, *p* \< 0.001) were significant risk factors for FQ-R. Among the 142 subjects, FQ MICs of *Escherichia coli*from urine or blood were available in 64 patients, and ECR according to FQ MIC was analyzed: 72.5% (29/40) in patients with MIC \<0.004 ∼ 0.125 µg/ml, 76.9% (10/12) with 0.19 ∼ 3 µg/ml, 80% (4/5) with 4 ∼ 16 µg/ml and 57.1% (4/7) with \>32 µg/ml.

***Conclusion.*** Risk factors of FQ-R were age \>65 years and history of antibiotics usage within 1 year, and duration of hospitalization was longer in FQ-R than FQ-S group. Patients with FQ MIC ≤16 µg/ml showed a similar ECR to those with susceptible isolates.
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